MPTP: current concepts and controversies.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D001921:Brain / Q000187:drug effects*; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011725:Pyridines / Q000494:pharmacology*; D014714:Vertebrates
D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine